| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
275.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
22 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kirk Randal J |
Chief Executive Officer |
• • • |
2018-04-30 |
4 |
A |
$18.18 |
$999,984 |
I/I |
51,775 |
14,788,996 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2018-03-30 |
4 |
A |
$15.33 |
$999,979 |
I/I |
60,551 |
14,777,995 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$62,995 |
D/D |
3,987 |
47,144 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$68,999 |
D/D |
4,367 |
76,129 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$56,485 |
D/D |
3,575 |
21,678 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$56,485 |
D/D |
3,575 |
6,414 |
|
- |
|
| Turley James S |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$62,489 |
D/D |
3,955 |
13,550 |
|
- |
|
| Frank Steven |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$49,991 |
D/D |
3,164 |
192,257 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2018-03-23 |
4 |
A |
$15.80 |
$56,485 |
D/D |
3,575 |
13,281 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2018-02-28 |
4 |
A |
$13.02 |
$999,985 |
I/I |
74,097 |
14,764,949 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2018-02-20 |
4 |
OE |
$2.64 |
$23,512 |
D/D |
8,906 |
114,849 |
|
- |
|
| Frank Steven |
Director |
– • – |
2018-02-12 |
4 |
OE |
$2.64 |
$23,512 |
D/D |
8,906 |
189,093 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2018-01-31 |
4 |
A |
$13.00 |
$999,981 |
I/I |
69,768 |
14,749,589 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2018-01-19 |
4 |
B |
$12.50 |
$12,500,000 |
I/I |
1,000,000 |
7,782,622 |
2.64 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-12-29 |
4 |
A |
$11.33 |
$14,686,410 |
I/I |
1,288,632 |
886,491 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-11-30 |
4 |
A |
$12.65 |
$999,988 |
I/I |
77,903 |
13,508,864 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-10-31 |
4 |
A |
$16.35 |
$999,991 |
I/I |
56,701 |
13,494,202 |
|
- |
|
| Reed Thomas D. |
Chief Science Officer |
• – – |
2017-10-16 |
4 |
OE |
$2.64 |
$101,899 |
D/D |
38,598 |
102,715 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-09-29 |
4 |
A |
$19.01 |
$999,966 |
I/I |
51,820 |
13,481,970 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-08-31 |
4 |
A |
$18.63 |
$999,974 |
I/I |
53,077 |
13,471,450 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2017-08-22 |
4 |
B |
$17.61 |
$52,830 |
I/I |
3,000 |
3,000 |
2.1 |
- |
|
| Shapiro Robert B |
Director |
– • – |
2017-08-22 |
4 |
B |
$17.50 |
$49,883 |
I/I |
2,850 |
82,966 |
2.1 |
- |
|
| Last Andrew J. |
Chief Operating Officer |
• – – |
2017-08-14 |
4 |
B |
$19.99 |
$39,980 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2017-08-11 |
4 |
B |
$18.32 |
$99,661 |
D/D |
5,440 |
71,762 |
2.39 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-08-11 |
4 |
B |
$18.85 |
$2,499,981 |
I/I |
132,625 |
6,782,622 |
2.64 |
- |
|
689 Records found
|
|
Page 21 of 28 |
|
|
0.01 (0.65%) 
